Skip to content
OUR SOLUTIONS
triSure
SPOT-MAS
K-TRACK | K-4CARE
ABOUT US
Our Vision
Our Laboratories
Leadership Team
Contact us
OUR SCIENCE
Publications & Abstracts
NEWS & INSIGHTS
OUR SOLUTIONS
triSure
SPOT-MAS
K-TRACK | K-4CARE
ABOUT US
Our Vision
Our Laboratories
Leadership Team
Contact us
OUR SCIENCE
Publications & Abstracts
NEWS & INSIGHTS
Establishment and Assessment of a Non-invasive Prenatal Testing Protocol for 22q11.2 Deletion Syndrome
February 1, 2024
Prev
Previous Article
Gene Solutions Announces Publication of Ground-breaking Study on AI-Driven Tumor-Specific Methylation Atlas
Next Article
De novo Variants of Dominant Monogenic Disorders in Vietnam Detected by a Noninvasive Prenatal Test: A Case Series
Next